Seer (SEER) Asset Writedowns and Impairment (2022 - 2026)
Seer (SEER) recorded quarterly Asset Writedowns and Impairment of -$10000.0 in Q1 2026, down 116.39% quarter-over-quarter from $61000.0 in Q4 2025, and down 130.3% on a YoY basis from $33000.0 in Q1 2025.
Seer (SEER) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends
Seer's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 130.3% year-over-year to -$10000.0; the TTM figure through Mar 2026 stood at $105000.0 (down 48.53% YoY), while the FY2025 annual figure was $148000.0, down 17.32% from the prior year.
- Asset Writedowns and Impairment was -$10000.0 for Q1 2026 at Seer, down from $61000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $525000.0 in Q3 2023 to a low of -$10000.0 in Q1 2026.
- Historically, Asset Writedowns and Impairment has averaged $130461.5 across 5 years, with a median of $54000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment soared 312.5% in 2025, then sank 130.3% in 2026.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $507000.0 in 2022, then tumbled by 90.73% to $47000.0 in 2023, then grew by 10.64% to $52000.0 in 2024, then gained by 17.31% to $61000.0 in 2025, then slumped by 116.39% to -$10000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at -$10000.0 (Q1 2026), $61000.0 (Q4 2025), and $54000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | 525,000.00 |
| Sep 30, 2023 | 525,000.00 |